Cytogen Corp. (CYTO)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS
*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

650 COLLEGE RD EAST STE 3100 PRINCETON, NJ 08540

Cytogen Corp. acquires, develops and commercializes innovative molecules targeting the sites and stages of cancer progression. Marketed products of this biopharmaceutical company include QUADRAMET and PROSTASCINT kit for the preparation of Indium In-111 capromab pendetide in the U.S.

View SEC Filings from CYTO instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
No data found for this quarter.
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding CYTO (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CYTO BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

BAGALAY JOHN E JR

  • Director
No longer subject to file 2008-05-08 0

GRIGSBY JAMES A

  • Director
No longer subject to file 2008-05-08 0

HENDRICKSON ROBERT F

  • Director
No longer subject to file 2008-05-08 0

MOLLICA JOSEPH A

  • Director
No longer subject to file 2008-05-08 0

BLOOM ALLEN

  • Director
No longer subject to file 2008-05-08 0

BRATTON KEVIN J SR. VP, CFO

  • Officer
No longer subject to file 2008-05-08 0

GOECKELER WILLIAM F SR. VP, OPERATIONS

  • Officer
No longer subject to file 2008-05-08 0

LOKAY KEVIN G

  • Director
No longer subject to file 2008-05-08 0

LANGER DENNIS

  • Director
No longer subject to file 2008-05-08 0

ROSS STEPHEN A SR. V.P., SALES & MARKETING

  • Officer
No longer subject to file 2008-05-08 0

CARTER STEPHEN

  • Director
No longer subject to file 2008-05-08 0

J.P. MORGAN VENTURES CORP

  • 10% Owner
0 2008-05-08 0

EUSA PHARMA INC

  • 10% Owner
36,093,873 2008-05-08 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments